Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?

Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?

In Japan, healthcare workers (HCWs) are vaccinated against measles, rubella, chickenpox, mumps, and hepatitis B to prevent nosocomial infection; however, some do not produce sufficient antibodies (“suboptimal responders”). This study compared immune responses to a severe acute respiratory syndrome c...

Full description

Bibliographic Details
Main Authors: Wataru Ogura, Kouki Ohtsuka, Sachiko Matsuura, Takahiro Okuyama, Satsuki Matsushima, Satoko Yamasaki, Hiroyuki Miyagi, Kumiko Sekiguchi, Hiroaki Ohnishi, Takashi Watanabe
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Viruses
Subjects:
coronavirus disease 2019
severe acute respiratory syndrome coronavirus 2
mRNA vaccine
anti-spike antibody
neutralizing antibody
Online Access:https://www.mdpi.com/1999-4915/14/5/956

Internet

https://www.mdpi.com/1999-4915/14/5/956

Similar Items